Liquid Biopsy in Cancer

Overview

Liquid biopsy is an important breakthrough in the diagnosis and treatment of cancer. It is a minimally invasive procedure that uses a small sample of liquid, such as blood, to detect the presence of cancer-related DNA or proteins. By analyzing the sample, doctors can detect early signs of cancer, accurately identify the stage of the disease, and decide on the most effective treatment. Liquid biopsy is an invaluable tool for monitoring a patient's progress and responding quickly to changes in tumor status. Additionally, it can provide information about the genetic makeup of a cancer, helping doctors choose the best treatment for the individual situation. It is also quickly becoming an important tool for personalized medicine.

Research published in this journal

4 peer-reviewed articles, ranked by relevance. Each links to its DOI.

How this research is being cited

The 4 articles above have been cited 4 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.

• MicroRNAs in melanoma progression and metastasis: From mechanisms to therapy resistance
  2026 · Human Gene
• Molecular Detection of Helicobacter pylori and Epstein- Barr Virus Co-infection among Sudanese Gastritis Patients, Khartoum State- Sudan
  2026 · Biomedical & Pharmacology Journal
• EBV-associated epigenetic signature in a colorectal cancer multicase family.
  2023 · Research Square (Research Square)
• Association Of Epstein-Barr Virus With Gastric Carcinoma Among Sudanese Patients
  2016 · Journal of Cancer Genetics and Biomarkers

A sample of recent works citing this journal's research on Liquid Biopsy in Cancer, linking to each citing work.

This page summarises published research for orientation; it is not medical or professional advice.

Related topics